Arbutus Biopharma
ABUS
ABUS
18 hedge funds and large institutions have $8.95M invested in Arbutus Biopharma in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$379K | |
| 2 | +$319K | |
| 3 | +$239K | |
| 4 |
OAM
Orinda Asset Management
Lafayette,
California
|
+$84K |
| 5 |
LOM
Loeb Offshore Management
New York
|
+$70K |
Top Sellers
| 1 | -$773K | |
| 2 | -$602K | |
| 3 | -$16.5K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5.46K |